The Exchange had sought clarification from Fischer Medical Ventures Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted. The response of the Company is enclosed.
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE asked Fischer Medical Ventures Limited to clarify why segment-wise details were not included in its financial results for the quarter ended 31 December 2025, as required under Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements. The company has now submitted its response to the exchange. This is a routine compliance query and not a punitive action. Investors should look for the actual segment data in the company's response to assess its business breakdown.
This is a minor compliance matter and is unlikely to materially affect the stock price. No penalty or regulatory action has been imposed — the company has simply addressed the exchange's clarification request.